IRF6 and neoplasm: Studies have shown that IRF6 is low expressed in gastric cancer [14], and it has been recently reported that increased IRF6 expression can inhibit the proliferation, invasion and tumorigenicity of breast cancer cells and enhance the sensitivity of tumor cells to chemotherapy drugs [15].